Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: Cambridge Enterprise

Lumora – innovative molecular diagnostics

Posted on by

Lumora is a biotech company applying its proprietary technology to propose innovative molecular diagnostics in sample preparation, amplification and detection. Lumora aims to reduce the complexity of molecular testing.

Lumora – innovative molecular diagnostics

Lumora

Continue reading →

Posted in Biotech Companies, Biotech Companies UK | Tagged 3M, 3M Molecular Detection System, AIDS, BART, Bioluminescent Assay in Real Time, C. difficile, C. difficile assay, C. difficile Associated Disease, Cambridge Enterprise, Catapult Venture Managers, CDAD, Clostridium difficile, Clostridium difficile test, HAI, Hayden Jeffreys, HE, Heat Elution, HIV, Hospital acquired infections, innovative molecular diagnostic, innovative molecular diagnostics, Jim Murray, Laurence Tisi, Lumora, Lumora - innovative molecular diagnostics, malaria, malaria diagnostic assay, Molecular Detection System, molecular diagnostic, Next Generation Quantification application, Next Generation Quantification applications, NGQ, Promega, RapidMag, Rob Sprawson, Tate Lyle Ventures, Ultra-Glo luciferase

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress